Le point sur la fibromyalgie

[en] OBJECTIVE: To realize a clarification about fibromyalgia, attempting to consider diagnostic criteria, prevalence, pathophysiology and therapeutic approach. METHOD: A systematic literature search was conducted to select articles about fibromyalgia and connected diseases. The database are Premedline, Medline and Medlineplus. RESULTS: Fifty-eight articles about fibromyalgia and twelve articles about connected diseases were selected to realize this review of literature. DISCUSSION: Fibromyalgia constitutes a syndrome characterized by widespread musculo-skeletal pain, present above the waist and below the waist and in the axial skeleton. Widespread pain must have been present for at least three months. "Spasmophilie", chronic fatigue syndrome and myofascial syndrome represent diseases connected with fibromyalgia: differential diagnosis must be established. Researches related to fibromyalgia suggest a reduction of muscular performances associated with histological and biochemical anomalies. Patients are characterized by shorter and nonrestorative sleep. Psychological, neuroendocrine and central alterations appear often associated with fibromyalgia. The reduction of pressure tolerance and pain thresholds may be linked to the alterations of neuroendocrine substances. Literature recommend a multidisciplinary therapeutic approach in management of fibromyalgia. CONCLUSION: The pathophysiologic mechanisms in fibromyalgia appear multiple and interdependent. With the aim to optimizing treatment, investigations are necessary to determine biochemical repercussions of various therapeutic approaches.

Disciplines :

Orthopedics, rehabilitation & sports medicine

Author, co-author :

Maquet, Didier ; Université de Liège - ULiège > Département des sciences de la motricité > Département des sciences de la motricité

Croisier, Jean-Louis ; Université de Liège - ULiège > Département des sciences de la motricité > Kinésithérapie générale et réadaptation

Crielaard, Jean-Michel ; Université de Liège - ULiège > Département des sciences de la motricité > Evaluation et entraînement des aptitudes physiques

Language :

French

Title :

Le point sur la fibromyalgie

Alternative titles :

[en] What Happens to the Fibromyalgia Syndrome?

Publication date :

July 2001

Journal title :

Annales de Réadaptation et de Médecine Physique

ISSN :

0168-6054

Publisher :

Elsevier, Netherlands

Volume :

Issue :

Pages :

316-25

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 29 April 2009

Statistics

Number of views

209 (24 by ULiège)

Number of downloads

11 (5 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Aaron L.A., Bradley L.A., Alarcon G.S., Triana-Alexander M., Alexander R.W., Martin M.Y. (1997) Perceived physical and emotional trauma as precipitating events in fibromyalgia. Arthritis Rheum 40:453-460.
Aaron L.A., Burke M.M., Buchwald D. (2000) Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia and temporomandibular disorder. Arch Intern Med 160:221-227.
Ayavou T., Marie P.A., Zakarian H., Eisinger J. (1996) Oxyde nitrique et fibromyalgie. LMM Med du Sud Est 32:2194-2196.
Bastin J.M. (1981) La spasmophilie. Acta Rheumatologica Belgica 5:41-48.
Bennett R.M., Burckhardt C.S., Clark S.R., O'Reilly C.A. (1996) Group treatment of fibromyalgia: A 6 month outpatient program. J Rheumatol 23:521-528.
Bennett R.M., Clark S.C., Walczyk J. (1998) A randomized, double-blind, placebo-contolled study of growth hormone in the treatment of fibromyalgia. Am J Med 104:227-231.
Benoist M., Boulu P.H., Fuster J.M., Kahn M.F., Cambier J. (1986) Le syndrome polyalgique idiopathiqne diffus. Press Med 15:1680-1682.
Boisset-Pioro M., Esdaile J.M., Fitzcharles M.A. (1995) Sexual and physical abuse in women with fibromyalgia syndrome. Arthritis Rheum 38:235-241.
Branco J., Atalaia A., Paiva T. (1994) Sleep cycles and alpha-delta sleep in fibromyalgia syndrome. J Rheumatol 21:1113-1117.
Buskila D., Shnaider A., Neumann L., Zilberman D., Hilzenrat N., Sikuler E. (1997) Fibromyalgia in hepatitis C virus infection. Arch Intern Med 157:2497-2500.
Carette S., Bell M.J., Reynolds W.H., Haraoui B., McCain G.A., Bykerk V.P. (1994) Comparison of Amitriptyline, Cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 37:32-40.
Caruso I., Sarzi Puttini P.C., Cazzole M. (1987) Double-blind study of hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 15:154-159.
Clavel J.P., Emerit J., Thuillier A. (1985) Lipid peroxydation and free radicals. Role in cellular biology and pathology. Pathol Biol 33:61-69.
Crielaard J.M., Clara D., Maertens de Noordhout B., Franchimont P. (1986) Étude de la spasmorythmie dans une population sportive. Son rapport avec la pathologie musculaire. Acta Belgica-Medica Physica 9:159-161.
Crofford L.J. (1998) Neuroendocrine abnormalities in fibromyalgia and related disorders. Am J Med Sci 315:359-365.
Danneskiold-Samsoe B., Kamper-Jorgesen F. (1993) Fibromyalgia in the adult Danish population. II. A study of clinicals features. Scand J Rheumatol 22:238-242.
Eich W., Hartmann M., Nuller A., Fischer H. (2000) The role of psychosocial factors in fibromyalgia syndrome. Scand J Rheumatol 113(SUPPL.):30-31.
Eisinger J., Dupond J.L., Cozzone P.J. (1996) Anomalies de la glycolyse au cours des fibromyalgies: Études biologique et thérapeutique. LMM Med du Sud Est 32:2180-2183.
Eisinger J., Geoffroy M., Planturama A., Zakarian H., Ayavou T. (1996) Métabolisme énergétique et statut antioxydant au cours des myalgies. II - Fibromyalgie. LMM Méd du Sud-Est 32:2171-2174.
Eisinger J., Planturama A., Ayavou T. (1994) Gycolysis abnormalities in fibromyalgia. J Am Coll Nutr 13:144-148.
Eisinger J., Zakarian H., Ayavou T. (1997) Dosage de la carnitine plasmatique au cours des fibromyalgies. LMM Méd du Sud Est 32:2369-2371.
Elert J.E., Dahlqvist S.B., Larsen K., Lorentzon R., Gerdle B.U.C. (1992) Muscle performance, electromyography and fibre type composition in fibromyalgia and work-related myalgia. Scand J Rheumatol 21:28-34.
Engelbeen J.P., Huaux J.P., Knoops, Guisset P.J., Turine B., Ketelslegers J.M. (1981) Étude clinique et biologique de la spasmorythmie: Ses rapports avec la spasmophilie, rôle du magnésium. Acta Rheumatologica Belgica 5:71-104.
Gerster J.C. (1999) Fibromyalgie. Le passé, le présent. Rev Med Suisse Rom 119:513-516.
Giovengo S.L., Russell I.O., Larson A.A. (1999) Incresead concentrations of nerve growth factor in cerebrospninal fluid of patients with fibromyalgia. J Rheumatol 26:1564-1569.
Gupta S., Aggarwal S., See D., Staer A. (1997) Cytokines production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J Psychiatr Res 31:149-156.
Hagberg M., Kavarnstroem S. (1984) Muscular endurance and electromyographic fatigue in myofascial shoulder pain. Arch Phys Med Rehab 65:522-525.
Hakkinen A., Hakkinen K., Hannonen P., Alen M. (2001) Strenght training induced adaptations in neuromuscular function of premenopausal women with fibromyalgia: Comparison with healthy women. Ann Rheum Dis 60:21-26.
Hapidor E.G., Rollman G.B. (1998) Menstrual cycle modulation of tender points. Pain 77:151-161.
Harding S.M. (1998) Sleep in fibromyalgia patients: Subjective and objective findings. Am J Med Sci 315:367-375.
Houvenagel E. (1999) Les mécanismes de la douleur de la fibromyalgie. Rev Rhum 66:105-110.
Jacobsen S., Wildschiodtz G., Danneskold-Samsoe B. (1991) Isokinetic and isometric muscle strength combined with transcutaneous electrical muscle stimulation in primary fibromyalgia syndrome. J Rheumatol 18:1390-1393.
Keel P.J., Bodoky C., Gerhard U., Muller W. (1998) Comparison of integrated group therapy and group relaxation training for fibromyalgia. Clin J Pain 14:232-238.
Klein R., Bansch M., Berg P.A. (1992) Clinical relevance of antibodies against serotonin and gangliosides in patients with primary fibromyalgia syndrome. Psychoneuroendocrinology 17:593-598.
Krag N.J., Norregaard J., Larsen J.K., Danneskiold-Samsoe B. (1994) A blinded, controlled evaluation of anxiety and depressive symptoms in patients with fibromyalgia, as measured by standardized psychometric interview scales. Acta Psychiatr Scand 89:370-375.
Lindh M.H., Johansson L.A., Hedberg M., Grimby G.L. (1994) Studies on maximal voluntary muscle contraction in patients with fibromyalgia. Arch Phys Med Rehabil 75:1217-1222.
McCain G.A. (1996) A cost-effective approach to the diagnosis and treatment of fibromyalgia. Rheum Dis Clin North Am 22:323-349.
Mengshoel A.M., Forre O., Komnaes H.B. (1990) Muscle stregnth and aerobic capacity in primary fibromyalgia. Clin Exp Rheumatol 8:475-479.
Mengshoel A.M., Forseth K.O., Haugen M., Walle-Hansen R., Forre O. (1995) Multidisciplinary approach to fibromyalgia. A pilot study. Clin Rheumatol 14:165-170.
Moldofsky H., Saskin P., Lue F.A. (1981) Sleep and musculoskeletal pain. Am J Med 3(SUPPL.):85-89.
Mountz J.M., Bradley L.A., Alarcon G.S. (1998) Abnormal functional activity of the central nervous system in fibromyalgia syndrome. Am J Med Sci 315:385-395.
Olsen N.J., Park J.H. (1998) Skeletal muscle abnormalities in patients with fibromyalgia. Am J Med Sci 315:351-358.
Papadopoulos I., Geogiou P.E., Katsimbri P.P., Drosos A.A. (2000) Treatment of fibromyalgia with tropisetron, a 5 HT3 serotonin antagonist: A pilot study. Clin Rheumatol 19:6-8.
Park J.H., Phothimat P., Oates C.T., Schulman M.H., Olsen N.J. (1998) Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis Rheum 41:406-413.
Plesh O., Wolfe F. (1996) The relationship between fibromyalgia and temporomandibular disorders: Prevalence and symptom severity. J Rheumatol 23:1948-1952.
Reinhard P., Schweinsberg F., Wernet D., Kotter I. (1998) Selenium status in fibromyalgia. Toxycol Lett 96:177-180.
Riley J.L., Robinson M.E., Wise E.A., Myers C.D., Fillingim R.B. (1998) Sex differences in the perception of noxious experimental stimuli: A meta-analysis. Pain 74:181-187.
Russell J. (1998) Advances in fibromyalgia: Possible role for central neurochemicals. Am J Med Sci 315:377-384.
Russell I.J., Fletcher E.M., Michalek J.E., Miner J.C., Rahe A., Silva J. (1991) Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprozolam. A double-blind, placebo-controlled study. Arthritis Rheum 34:552-560.
Sprott H., Muller A., Heine H. (1997) Collagen crosslinks in fibromyalgia. Arthritis Rheum 40:1450-1454.
Thomas D.A., Ren K., Ruda M.A., Dubner R. (1996) Application of oxide synthase inhibitor, N omega-nitro-L-arginine methyl ester, on injured nerve attenuates neuropathy-induced thermal hyperalgesia in rats. Neurosci Lett 210:124-126.
Travell J., Simons D. (1983) Myofascial pain and dysfunction. The trigger point manual, Baltimore: Williams and Witkins; .
Turk D.C., Okifuji A., Sinclair D., Starz T. (1998) Interdisciplinary treatment for fibromyalgia syndrome: Clinical and statistical significance. Arthritis Care Res 11:186-195.
Van Houdenhove B., Fischler B., Neerinckx E. (1998) Le syndrome de fatigue chronique: Aboutissement d'un processus multifactoriel. Neurone 3:31-38.
Villanova M., Selvi E., Malandrini A., Casali C., Santorelli F.M., De Stefano R. (1999) Mitochondrial myopathy mimicking fibromyalgia syndrome. Muscle Nerve 2:289-290.
Volkmann H., Norregaard J., Jacobsen S., Danneskiold-Samsoe B., Knoke G., Nehrdich D. (1997) Double-blind, placebo-controlled crossover study of intravenous S-adenosyl-L-methionine in patients with fibromyalgia. Scand J Rheumatol 26:206-211.
Wallace D.J. (1997) The fibromyalgia syndrome. Ann Med 29:9-21.
Weigent D.A., Bradley L.A., Blalock E., Alarcon G.S. (1998) Current concepts in the pathophysiology of abnormal pain perception in fibromyalgia. Am J Med Sci 315:405-411.
Westhovens R. (1994) La fibromyalgie, un nouveau diagnostic?. Rheumatol 1:1-12.
White K.P., Speechley M., Harth M., Ostbye T. (2000) Co-existence of chronic fatigue syndrome with fibromyalgia in the general population. Scand J Rheumatol 29:44-51.
Whiteside T.L., Friberg D. (1998) Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 105:27-33.
Wikner J., Hirsch U.L.F., Wetterberg L., Röjdmark S. (1998) Fibromyalgia - A syndrome associated with decreased nocturnal melatonin secretion. Clin Endrocrinol 49:179-183.
Wilke W.S. (1996) Fibromyalgia. Recognizing and addressing the multiple interrelated factors. Postgrad Med 100:153-170.
Wilke W.S. (1995) Treatment of "resistant" fibromyalgia. Rheum Dis Clin North Am 21:247-261.
Wilson R.B., Gluck O.S., Tesser J.R.P., Rice J.C., Meyer A., Bridges A.J. (1999) Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity. J Rheumatol 26:402-407.
Winfield J.B. (1999) Pain in fibromyalgia. Rheum Dis Clin North Am 25:55-79.
Wolfe F. (1989) Fibromyalgia: The clinical syndrome. Rheum Dis Clin North Am 15:1-18.
Wolfe F., Ross K., Anderson J., Russell I.J., Hebert L. (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19-28.
Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L. (1990) The American College of Rheumatology Criteria for the classification of fibromyalgia. Arthritis Rheum 33:160-172.
Yunus M.B., Masi A.T., Calabro J.J., Miller K.A., Feigenbaum S.L. (1981) Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 11:151-171.